Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy

Journal of Neuroimaging

Volumn 24, Issue 4, 2014, Pages 425-428

  Eisele, Philipp ^a   Szabo, Kristina ^a   Hornberger, Eva ^a   Griebe, Martin ^a   Hennerici, Michael G ^a   Kieseier, Bernd C ^b   Gass, Achim ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY; NATALIZUMAB;

BRAIN; CASE REPORT; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; HUMAN; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN; FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84904403081     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12010     Document Type: Article

References (8)

1. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006;354:924-933.
2. Major EO. Reemergence of PML in natalizumab-treated patients-new cases, same concerns. N Engl J Med 2009;361:1041-1043.
3. Ryschkewitsch CF, Jensen PN, Monaco MC, et al. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 2010;68:384-391.
4. Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 2009;361:1075-1080.
5. Linda H, von Heijne A, Major EO, et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 2009;361:1081-1087.
6. Bag AK, Cure JK, Chapman PR, Roberson GH, et al. JC virus infection of the brain. AJNR Am J Neuroradiol 2010;31:1564-1576.
7. Kuhle J, Gosert R, Bühler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology 2011;77:2010-2016.
8. Yousry TA, Pelletier D, Cadavid D, et al. MRI pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol, 2012;72:779-787.